NO953286L - Benstimulerende faktor - Google Patents
Benstimulerende faktorInfo
- Publication number
- NO953286L NO953286L NO953286A NO953286A NO953286L NO 953286 L NO953286 L NO 953286L NO 953286 A NO953286 A NO 953286A NO 953286 A NO953286 A NO 953286A NO 953286 L NO953286 L NO 953286L
- Authority
- NO
- Norway
- Prior art keywords
- gly
- polypeptide
- lys
- ala
- pro
- Prior art date
Links
- 230000004936 stimulating effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 9
- 229920001184 polypeptide Polymers 0.000 abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 8
- 241000700159 Rattus Species 0.000 abstract 5
- 150000001413 amino acids Chemical class 0.000 abstract 3
- PEZMQPADLFXCJJ-ZETCQYMHSA-N 2-[[2-[[(2s)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]acetyl]amino]acetic acid Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(O)=O PEZMQPADLFXCJJ-ZETCQYMHSA-N 0.000 abstract 2
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 abstract 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 abstract 2
- 108010043293 glycyl-prolyl-glycyl-glycine Proteins 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 abstract 1
- OGMDXNFGPOPZTK-GUBZILKMSA-N Asn-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N OGMDXNFGPOPZTK-GUBZILKMSA-N 0.000 abstract 1
- YXPNKXFOBHRUBL-BJDJZHNGSA-N Cys-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N YXPNKXFOBHRUBL-BJDJZHNGSA-N 0.000 abstract 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 abstract 1
- GLYJPWIRLBAIJH-UHFFFAOYSA-N Ile-Lys-Pro Natural products CCC(C)C(N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(O)=O GLYJPWIRLBAIJH-UHFFFAOYSA-N 0.000 abstract 1
- NJMXCOOEFLMZSR-AVGNSLFASA-N Leu-Met-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O NJMXCOOEFLMZSR-AVGNSLFASA-N 0.000 abstract 1
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 abstract 1
- XOQMURBBIXRRCR-SRVKXCTJSA-N Lys-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN XOQMURBBIXRRCR-SRVKXCTJSA-N 0.000 abstract 1
- OBZHNHBAAVEWKI-DCAQKATOSA-N Lys-Pro-Asn Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O OBZHNHBAAVEWKI-DCAQKATOSA-N 0.000 abstract 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 abstract 1
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 abstract 1
- XIULAFZYEKSGAJ-IXOXFDKPSA-N Thr-Leu-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XIULAFZYEKSGAJ-IXOXFDKPSA-N 0.000 abstract 1
- WFAUDCSNCWJJAA-KXNHARMFSA-N Thr-Lys-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(O)=O WFAUDCSNCWJJAA-KXNHARMFSA-N 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000010256 bone deposition Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
- 231100000673 dose–response relationship Toxicity 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 108010015792 glycyllysine Proteins 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 239000002853 nucleic acid probe Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 108010071097 threonyl-lysyl-proline Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3138693A | 1993-03-12 | 1993-03-12 | |
US12021793A | 1993-09-13 | 1993-09-13 | |
PCT/CA1994/000144 WO1994020615A1 (en) | 1993-03-12 | 1994-03-14 | Bone stimulating factor |
Publications (2)
Publication Number | Publication Date |
---|---|
NO953286D0 NO953286D0 (no) | 1995-08-22 |
NO953286L true NO953286L (no) | 1995-10-25 |
Family
ID=26707172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953286A NO953286L (no) | 1993-03-12 | 1995-08-22 | Benstimulerende faktor |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0688360B1 (es) |
JP (1) | JP3733381B2 (es) |
KR (1) | KR960701201A (es) |
CN (1) | CN1119457A (es) |
AT (1) | ATE208818T1 (es) |
AU (1) | AU678441B2 (es) |
BR (1) | BR9406447A (es) |
CA (1) | CA2157901A1 (es) |
CZ (1) | CZ234295A3 (es) |
DE (1) | DE69429082T2 (es) |
ES (1) | ES2168295T3 (es) |
FI (1) | FI954252A0 (es) |
HU (1) | HUT73297A (es) |
IL (1) | IL108947A0 (es) |
NO (1) | NO953286L (es) |
NZ (1) | NZ262352A (es) |
PL (1) | PL182236B1 (es) |
TW (1) | TW385314B (es) |
WO (1) | WO1994020615A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786327A (en) | 1993-03-12 | 1998-07-28 | Gensci Regeneration Sciences Inc. | Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same |
US6352973B1 (en) | 1995-06-07 | 2002-03-05 | Osteopharm Inc. | Bone stimulating factor |
US5880094A (en) * | 1995-06-07 | 1999-03-09 | Osteopharm Limited | Polypeptides that stimulate bone growth |
US6117839A (en) * | 1995-06-07 | 2000-09-12 | Gensci Regeneration Sciences, Inc. | Bone stimulating factor |
US6693081B2 (en) | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
US6316262B1 (en) | 1997-09-19 | 2001-11-13 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
DE19906096A1 (de) | 1999-02-13 | 2000-08-17 | Walter Sebald | Protein mit einem Heparin-bindenden Epitop |
AU5379200A (en) * | 1999-06-02 | 2000-12-28 | Osteopharm Inc. | Bone stimulating factor |
DE60026150T2 (de) | 1999-08-30 | 2006-11-16 | Interleukin Genetics, Inc., Waltham | Diagnostika und therapeutika für osteoporose |
US6815421B1 (en) | 2001-03-22 | 2004-11-09 | Osteopharm Inc. | Polypeptides for use in ameliorating effects of aging in mammals |
ATE490339T1 (de) | 2003-08-08 | 2010-12-15 | Interleukin Genetics Inc | Diagnostikum für osteoporose |
PL2118136T3 (pl) * | 2006-12-21 | 2011-04-29 | Corticalis As | Peptyd konsensusowy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1229789A (en) * | 1983-06-06 | 1987-12-01 | David Baylink | Polypeptides exhibiting skeletal growth factor activity |
CA2020729A1 (en) * | 1989-07-19 | 1991-01-20 | Michael C. Kiefer | Bone morphogenetic protein |
-
1994
- 1994-03-11 IL IL10894794A patent/IL108947A0/xx unknown
- 1994-03-14 BR BR9406447A patent/BR9406447A/pt not_active Application Discontinuation
- 1994-03-14 CA CA002157901A patent/CA2157901A1/en not_active Abandoned
- 1994-03-14 DE DE69429082T patent/DE69429082T2/de not_active Expired - Fee Related
- 1994-03-14 PL PL94310617A patent/PL182236B1/pl unknown
- 1994-03-14 WO PCT/CA1994/000144 patent/WO1994020615A1/en not_active Application Discontinuation
- 1994-03-14 HU HU9502659A patent/HUT73297A/hu unknown
- 1994-03-14 JP JP51844794A patent/JP3733381B2/ja not_active Expired - Fee Related
- 1994-03-14 KR KR1019950703855A patent/KR960701201A/ko not_active Application Discontinuation
- 1994-03-14 NZ NZ262352A patent/NZ262352A/en unknown
- 1994-03-14 AT AT94908917T patent/ATE208818T1/de not_active IP Right Cessation
- 1994-03-14 CZ CZ952342A patent/CZ234295A3/cs unknown
- 1994-03-14 CN CN94191456A patent/CN1119457A/zh active Pending
- 1994-03-14 ES ES94908917T patent/ES2168295T3/es not_active Expired - Lifetime
- 1994-03-14 AU AU61797/94A patent/AU678441B2/en not_active Ceased
- 1994-03-14 EP EP94908917A patent/EP0688360B1/en not_active Expired - Lifetime
- 1994-03-21 TW TW083102552A patent/TW385314B/zh not_active IP Right Cessation
-
1995
- 1995-08-22 NO NO953286A patent/NO953286L/no not_active Application Discontinuation
- 1995-09-11 FI FI954252A patent/FI954252A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
AU6179794A (en) | 1994-09-26 |
EP0688360B1 (en) | 2001-11-14 |
DE69429082D1 (de) | 2001-12-20 |
FI954252A (fi) | 1995-09-11 |
NZ262352A (en) | 1997-10-24 |
ES2168295T3 (es) | 2002-06-16 |
JP3733381B2 (ja) | 2006-01-11 |
EP0688360A1 (en) | 1995-12-27 |
PL182236B1 (pl) | 2001-11-30 |
CA2157901A1 (en) | 1994-09-15 |
ATE208818T1 (de) | 2001-11-15 |
CN1119457A (zh) | 1996-03-27 |
KR960701201A (ko) | 1996-02-24 |
HU9502659D0 (en) | 1995-11-28 |
PL310617A1 (en) | 1995-12-27 |
WO1994020615A1 (en) | 1994-09-15 |
DE69429082T2 (de) | 2002-07-25 |
JPH08508158A (ja) | 1996-09-03 |
TW385314B (en) | 2000-03-21 |
FI954252A0 (fi) | 1995-09-11 |
IL108947A0 (en) | 1994-06-24 |
BR9406447A (pt) | 1996-02-13 |
CZ234295A3 (en) | 1996-04-17 |
HUT73297A (en) | 1996-07-29 |
NO953286D0 (no) | 1995-08-22 |
AU678441B2 (en) | 1997-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69117788T2 (de) | Parathyroid-Hormon-Antagonisten | |
DE69323337T2 (de) | Derivate des Parathormons | |
US5665705A (en) | Glucagon analogs with serine replacements | |
JP2902115B2 (ja) | 新規アミリン作動薬ペプチドおよびその使用 | |
NO953286L (no) | Benstimulerende faktor | |
AU633913B2 (en) | Novel tnf-inhibit proteins and their preparation | |
IE850436L (en) | Peptides | |
DE69725850T2 (de) | Analoge des parathormons zur behandlung der osteoporose | |
AU5963290A (en) | Inhibition of the n-end rule pathway in living cells | |
RU2235099C2 (ru) | Антагонистические аналоги рилизинг-гормона гормона роста (gh-rh), ингибирующие инсулиноподобные факторы роста (igf-i и-ii) | |
WO1993012139A1 (en) | A novel molecule which inhibits neuropeptide tyrosine biological function | |
US20070287665A1 (en) | Urotensin-II agonists and antagonists | |
US5814610A (en) | Osteogenic growth oligopeptides and pharmaceutical compositions containing them | |
CA2248630A1 (en) | Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same | |
WO1988003537A1 (en) | Novel peptides | |
EP0341603A2 (en) | Atrial peptide derivatives | |
NZ233795A (en) | Derivatives of atrial natriuretic peptide (anp) | |
EDE et al. | Synthesis and conformation of constrained peptides with hypoglycaemic activity derived from human growth hormone | |
FUJII et al. | Studies on Peptides. CLVI. Synthesis of Second Human Calcitonin Gene-Related Peptide (β-hCGRP) by Application of a New Disulfide-Bonding Reaction with Thallium (III) Trifluoroacetate | |
Güllner et al. | Effect of porcine gastrin releasing peptide on anterior pituitary hormone release | |
AU2005202153B2 (en) | Urotensin-II agonists | |
Ganeshan et al. | Recognition of neuropeptides FMRFamide and LPLRFamide by chicken cerebellum avian pancreatic polypeptide binding sites | |
US6262230B1 (en) | Analogs of thymosin α1 | |
KR920700675A (ko) | 발기 기능장해 치료용 약물(칼시토닌 유전자 관련 펩티드) | |
JPH07278191A (ja) | 新規ペプチドもしくは蛋白質及びそれを探索する方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |